CHOC Research studies the use of artificial intelligence tools in detecting juvenile dermatomyositis (JDM), a rare autoimmune disorder.
CHOC IRB members serve critical role of protecting the rights of human research subjects
Meet members of CHOC’s institutional review boards (IRB), who protect the rights and welfare of pediatric patients recruited to participate in studies.
Cord closure: Sutureless gastroschisis repair at CHOC
Sutureless gastroschisis repair at CHOC allows infants to avoid anesthetization and ventilation and produces better cosmetic results.
UCI AI innovation challenge winners include students involved in pediatric research at CHOC
Students involved in CHOC’s Research Institute were on winning teams with projects utilizing AI to improve patient outcomes.
FDA approval grows use of growth therapy for children with achondroplasia
The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential.
CHOC-affiliated blood disorder center administers landmark gene therapy infusion for hemophilia
The center becomes the first in the country to administer a commercial gene therapy infusion to treat Hemophilia A, the common disorder affecting males.
